Metabolic Positron Emission Tomography in Breast Cancer
- 25 June 2023
- journal article
- research article
- Published by Elsevier in PET Clinics
- Vol. 18 (4) , 473-485
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2013
- The current state of breast cancer classificationAnnals of Oncology, 2012
- Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early RelapseJournal of Nuclear Medicine, 2012
- Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapyBMC Cancer, 2011
- Integrated Positron Emission Tomography/Computed Tomography May Render Bone Scintigraphy Unnecessary to Investigate Suspected Metastatic Breast CancerJournal of Clinical Oncology, 2010
- A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesAnnals of Oncology, 2006
- Unexpected Focal Hypermetabolic Activity in the Breast: Significance in Patients Undergoing 18F-FDG PET/CTAmerican Journal of Roentgenology, 2006
- FDG-PET and Beyond: Molecular Breast Cancer ImagingJournal of Clinical Oncology, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998